
MS Treatment Cladribine Provides Quality of Life Benefits and Improved Cognition Over 4-Year Period
New data from the phase 4 CLARIFY-MS extension trial (NCT04776213) continued to highlight the treatment benefits of cladribine tablets (Mavenclad; EMD Serono) on health-related quality of life (HRQoL) and cognition in patients with relapsing multiple …